The Peptide Supply Chain Reality 💰
So here's what I've discovered about how research companies are making BANK selling to medspas and compound pharmacies...
The Simple Business Model 📈
Research companies sell lyophilized (freeze-dried) peptides to medspas and compound pharmacies, who then turn around and charge patients massive markups.
The Numbers:
- Research company sells 10mg Semaglutide for ~$45-80
- Medspa/pharmacy charges patients $300-500+ for the same vial
- That's a 400-600% markup 🤯
How It Works 🔄
- Research Companies produce lyophilized peptides in bulk
- Medspas/Compound Pharmacies buy wholesale (usually $50-150/vial depending on peptide)
- End Customer gets charged $250-800+ for the exact same product
- Everyone wins except the patient's wallet
Popular Peptides & Markups 💉
Semaglutide (GLP-1):
- Wholesale: $45-80
- Retail: $300-500
- Markup: 500%+
Tirzepatide:
- Wholesale: $85-120
- Retail: $400-600
- Markup: 400-500%
BPC-157:
- Wholesale: $25-40
- Retail: $150-250
- Markup: 300-400%
Why This Model Works 🎯
✅ Medspas get consistent supply without pharma licensing hassles
✅ Compound pharmacies can offer "custom" formulations
✅ Research companies move volume at steady margins
✅ Patients think they're getting "premium compounded" products
The Supply Chain 📦
Research Company → Medspa/Pharmacy → Patient
The research companies handle:
- Manufacturing/sourcing
- Quality testing (COAs)
- Bulk packaging
- Wholesale distribution
The medspas/pharmacies handle:
- Customer acquisition
- Medical consultations
- Reconstitution/preparation
- Premium pricing/branding
Real Talk 💯
This is basically private labeling for the peptide world. Same product, different markup depending on where you buy it.
The research companies are smart - they focus on volume and consistency rather than dealing with end consumers. Let the medspas handle customer service, marketing, and compliance headaches.
Drop your experiences below - curious to see what pricing everyone else is seeing.
#MedSpa #Peptides #Wholesale #Markup #Business